ArticleMethods in molecular biology (Clifton, N.J.)2026
Methods and Guidelines for Analyzing the Conformational Dynamics of Proteins in the Antigen Presentation Pathway.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endoplasmic reticulum aminopeptidase 1 (ERAP1) digests antigenic precursors up to the optimum length for binding to the major histocompatibility complex (MHC) class I. This zinc-dependent aminopeptidase has been found in a catalytically active closed conformation and in open conformations that expose its substrate-binding cavity to the bulk solvent. Therefore, its activity has been linked to catalytic cycles between conformational states that accommodate substrate binding, peptide hydrolysis and product release. During the last decade, X-ray crystallography in conjunction with biophysical and enzymatic studies has deciphered the remarkable peptide-length dependence of ERAP1, the allosteric regulation mechanism, and the role of disease-associated polymorphisms. In this regard, molecular dynamics (MD) simulations have contributed to atomic-level investigations of ERAP1 conformational dynamics. This chapter provides a detailed protocol to generate the systems required to carry out and analyze atomistic MD simulations of ERAP1 with a bound inhibitor in explicit solvent, starting from different conformational states. This protocol is also applicable to the analysis of the conformational dynamics of other aminopeptidases in the antigen presentation pathway.
Indexed as
Identifiers
41479008What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.